Pelz, Johann Otto http://orcid.org/0000-0003-4391-2280
Kenda, Martin
Alonso, Angelika
Etminan, Nima
Wittstock, Matthias
Niesen, Wolf-Dirk
Lambeck, Johann
Güresir, Erdem
Wach, Johannes
Lampmannn, Tim
Dziewas, Rainer
Wiedmann, Markus
Schneider, Hauke
Bayas, Antonios
Christ, Monika
Mengel, Annerose
Poli, Sven
Brämer, Dirk
Lindner, Dirk
Pfrepper, Christian
Roth, Christian
Salih, Farid
Günther, Albrecht
Michalski, Dominik
,
Funding for this research was provided by:
Universitätsklinikum Leipzig
Article History
Received: 19 November 2022
Accepted: 9 June 2023
First Online: 27 July 2023
Conflict of interest
: FS reports personal fees from Bristol-Myers Squibb as well as MD Horizonte and AMEOS, both outside the submitted work. MW received speakers onoria and consulting fees from Alexion Pharma GmbH (formerly Portola). AG reports personal fees from Bristol-Myers Squibb, Boehringer-Ingelheim, Pfizer, Daichii Sankyo, Ipsen Pharma and Merz. JOP, MK, AA, NE, WDN, JL, EG, JW, TL, RD, MW, HS, AB, MC, AM, SP, DB, DL, CP, CR, and DM declare that there is no conflict of interest related to the presented work.
: This retrospective, noninterventional, multicenter study was performed according to the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendment. The study was approved by the local ethics committee of the University Hospital Leipzig, Leipzig, Germany (reference number 409/21-ek). If applicable, participating centers obtained the individual approval of the local ethics committee.